155 related articles for article (PubMed ID: 1873694)
1. Morphometric evidence for bone resorption and replacement in prostate cancer.
Clarke NW; McClure J; George NJ
Br J Urol; 1991 Jul; 68(1):74-80. PubMed ID: 1873694
[TBL] [Abstract][Full Text] [Related]
2. Generalised increase in bone resorption in carcinoma of the prostate.
Urwin GH; Percival RC; Harris S; Beneton MN; Williams JL; Kanis JA
Br J Urol; 1985 Dec; 57(6):721-3. PubMed ID: 4084733
[TBL] [Abstract][Full Text] [Related]
3. Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer.
Taube T; Elomaa I; Blomqvist C; Beneton MN; Kanis JA
Bone; 1994; 15(2):161-6. PubMed ID: 8086233
[TBL] [Abstract][Full Text] [Related]
4. Osteoblast function and osteomalacia in metastatic prostate cancer.
Clarke NW; McClure J; George NJ
Eur Urol; 1993; 24(2):286-90. PubMed ID: 8375452
[TBL] [Abstract][Full Text] [Related]
5. Disodium pamidronate identifies differential osteoclastic bone resorption in metastatic prostate cancer.
Clarke NW; McClure J; George NJ
Br J Urol; 1992 Jan; 69(1):64-70. PubMed ID: 1737255
[TBL] [Abstract][Full Text] [Related]
6. Skeletal response to clodronate in prostate cancer with bone metastases.
Fernández-Conde M; Alcover J; Aaron JE; Ordi J; Carretero P
Am J Clin Oncol; 1997 Oct; 20(5):471-6. PubMed ID: 9345330
[TBL] [Abstract][Full Text] [Related]
7. The effect of clodronate on bone in metastatic prostate cancer. Histomorphometric report of a double-blind randomised placebo-controlled study.
Taube T; Kylmälä T; Lamberg-Allardt C; Tammela TL; Elomaa I
Eur J Cancer; 1994; 30A(6):751-8. PubMed ID: 7917532
[TBL] [Abstract][Full Text] [Related]
8. Computed microtomography of bone specimens for rapid analysis of bone changes associated with malignancy.
Chappard D; Libouban H; Legrand E; Ifrah N; Masson C; Baslé MF; Audran M
Anat Rec (Hoboken); 2010 Jul; 293(7):1125-33. PubMed ID: 20583257
[TBL] [Abstract][Full Text] [Related]
9. Distinction between focally accelerated bone formation and osteomalacia in carcinoma of prostate metastasised to bone.
Taube T; Beneton MN; Williams JL; McCloskey EV; Kanis JA
Br J Urol; 1993 Jul; 72(1):98-103. PubMed ID: 8149187
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer and bone: the elective affinities.
Rucci N; Angelucci A
Biomed Res Int; 2014; 2014():167035. PubMed ID: 24971315
[TBL] [Abstract][Full Text] [Related]
11. Does increased local bone resorption secondary to breast and prostate cancer result in increased cartilage degradation?
Leeming DJ; Byrjalsen I; Qvist P; Koizumi M; Lynnerup N; Fregerslev M; Sørensen MG; Christiansen C; Karsdal MA
BMC Cancer; 2008 Jun; 8():180. PubMed ID: 18588674
[TBL] [Abstract][Full Text] [Related]
12. Histomorphometric analysis of osteoclastic bone resorption in metastatic bone disease from various primary malignomas.
Kulenkampff HA; Dreyer T; Kersjes W; Delling G
Virchows Arch A Pathol Anat Histopathol; 1986; 409(6):817-28. PubMed ID: 3094242
[TBL] [Abstract][Full Text] [Related]
13. Targeting the receptor activator of nuclear factor-kappaB (RANK) ligand in prostate cancer bone metastases.
Saad F; Markus R; Goessl C
BJU Int; 2008 May; 101(9):1071-5. PubMed ID: 18070191
[TBL] [Abstract][Full Text] [Related]
14. The effects of orchidectomy on skeletal metabolism in metastatic prostate cancer.
Clarke NW; McClure J; George NJ
Scand J Urol Nephrol; 1993; 27(4):475-83. PubMed ID: 8159920
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates in prostate carcinoma.
Adami S
Cancer; 1997 Oct; 80(8 Suppl):1674-9. PubMed ID: 9362435
[TBL] [Abstract][Full Text] [Related]
16. CD169(+) macrophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer.
Wu AC; He Y; Broomfield A; Paatan NJ; Harrington BS; Tseng HW; Beaven EA; Kiernan DM; Swindle P; Clubb AB; Levesque JP; Winkler IG; Ling MT; Srinivasan B; Hooper JD; Pettit AR
J Pathol; 2016 Jun; 239(2):218-30. PubMed ID: 27174786
[TBL] [Abstract][Full Text] [Related]
17. Bone response to invading tumors with spindle cell components: a report of findings in two patients.
Gruber HE; Schwinn CP; Kirchen ME; Moore TM; Marshall GJ
J Lab Clin Med; 1992 Oct; 120(4):639-44. PubMed ID: 1402340
[TBL] [Abstract][Full Text] [Related]
18. One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption.
Varela A; Chouinard L; Lesage E; Smith SY; Hattersley G
J Bone Miner Res; 2017 Jan; 32(1):24-33. PubMed ID: 27748532
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and histological evidence that carcinoma of the prostate is associated with increased bone resorption.
Percival RC; Urwin GH; Harris S; Yates AJ; Williams JL; Beneton M; Kanis JA
Eur J Surg Oncol; 1987 Feb; 13(1):41-9. PubMed ID: 3102281
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of bone metastasis in prostate cancer: clinical implications.
Msaouel P; Pissimissis N; Halapas A; Koutsilieris M
Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):341-55. PubMed ID: 18471791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
